Chemomab Therapeutics Ltd. (CMMB)
NASDAQ: CMMB · Real-Time Price · USD
1.380
-0.010 (-0.72%)
At close: Oct 9, 2026, 4:00 PM EDT
1.390
+0.010 (0.72%)
After-hours: Oct 9, 2026, 4:46 PM EDT
Chemomab Therapeutics Market Cap
Chemomab Therapeutics has a market cap or net worth of $10 million as of October 9, 2026. It is the 41,617th most valuable company in the world and the 5,642nd biggest in the United States. Its market cap has decreased by 44.78% in one year.
Market Cap
10.00M
Enterprise Value
3.31M
1-Year Change
-44.78%
Global Rank
Country Rank
#5,642 United States
Category
ChartMarket Cap Chart
Since March 17, 2021, Chemomab Therapeutics's market cap has decreased from $631.18M to $10.00M, a decrease of -98.42%. That is a compound annual growth rate of -52.51%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 9, 2026 | 10.00M | -1.55% |
| Dec 31, 2025 | 10.16M | -70.24% |
| Dec 31, 2024 | 34.13M | 466.14% |
| Dec 29, 2023 | 6.03M | -83.65% |
| Dec 30, 2022 | 36.88M | -53.12% |
| Dec 31, 2021 | 78.67M | -87.54% |
| Mar 17, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vistagen Therapeutics | 10.97M |
| Theriva Biologics | 10.74M |
| BioVie | 10.56M |
| Lisata Therapeutics | 10.54M |
| Purple Biotech | 10.54M |
| Adial Pharmaceuticals | 10.48M |
| Senti Biosciences Holdings | 10.28M |
| Immuron | 10.11M |